President Donald Trump has signed two executive orders aimed at reducing the cost of prescription drugs, but pharmaceutical benefit managers have been a small part of the legislation. Here’s what to k ...

In the end, the Senate didn’t bring it up for a vote. Sen. Kirk Talbot, R-River Ridge, took to the dais to introduce Senate ...

An upcoming bill from Sen. Bobby Harshbarger, R- Kingsport, would allow Tennessee more control over pharmacy benefit managers, commonly known as PBMs. The career pharmacist said the law will prevent ...

Marc Rabideau, a longtime San Francisco resident, went to the same Walgreens at the corner of 17th Avenue and Geary Boulevard ...

EDO Literacy Tahira Rafiq held a significant meeting with Assistant Director Pakistan Bait-ul-Mal (PBM) Muzaffargarh, Syed ...

PHOENIX, AZ, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Pharmacists United for Truth and Transparency (PUTT) today announced the launch of its "Audit TRICARE" campaign (AuditTRICARE.org), a ...

Republican Iowa state Rep. John Wills of Spirit Lake shares his highlights and disappointments from the 2025 legislative ...

Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings ...

Republican Iowa state Sen. Dave Rowley shares his highlights and disappointments of the 2025 legislative session including: ...

Kristin Begley's career has revolved around making prescriptions more accessible and affordable for individuals and companies ...

Investing.com -- CVS Health (NYSE: CVS) stock rose 1% on Wednesday after Bloomberg reported that Medicare Pharmacy Benefit Manager (PBM) limits were stripped from the Senate version of the tax bill.

Crispr investors have had a year to put aside so far, with the stock down 25%. Read more on CRSP's execution risks, high ...